Effect of additional cytogenetic abnormalities on survival in arsenic trioxide-treated acute promyelocytic leukemia
      QxMD      Google Scholar   
Citation:
Blood Adv vol 6 (11) 3433-9
Year:
2022
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
Alliance-data-source,-external-user
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Leukemia
Sec. Committees:
   
Pharmas:
 
Grants:
U10 CA180821, U10 CA180882  
Corr. Author:
 
Authors:
                                   
Networks:
 
Study
Alliance-A152008
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-9710
Phases:
N/A, 3
Keywords:
Myeloid Neoplasia